Author: Antonio Berlen

joimax® holds the first international TESSYS® User Meeting in Veenhuizen, The Netherlands, and announces the launch of various new products for endoscopic spinal surgery

Posted on by Antonio Berlen

Karlsruhe, 12. May 2010. On 14 and 15 May 2010 joimax® GmbH holds the first international user meeting of endoscopic spinal surgery in Veenhuizen/Netherlands. Besides the ten reference surgeons about 30 participants and customers from Germany, Europe, the United States and other countries are expected to join the meeting. The scientific program comprises atwo-days conference which be opened with a keynote lecture of Prof. Dr. Gerbrand J. Groen of the university of Utrecht. CEO and founder of the company Wolfgang Ries will give an outline of the product offensive in the coming months in the field of access systems, ablation and drilling systems and the latest joimax® HD technologies.

One of the highlights of this event will be the opening ceremony of Rugkliniek Iprenburg in Veenhuizen. The head of this private clinic Dr. Menno Iprenburg, a long-time member of the joimax® Faculty, having completed more than 900 TESSYS® surgeries, states: „It was the right decision to give up my position as chief surgeon in Assen and to risk once again total self-employment with the joimax® TESSYS® method“, and, „this is also proven by the significantly increasing number of patients and the possibility of operating more indications with the joimax® endoscopic methods “.

joimax Receives 510(k) Clearance for Percusys Pedicle Screw-Rod System

Posted on by Antonio Berlen

IRVINE, Calif., March 4, 2015 (GLOBE NEWSWIRE) — The German company joimax®, developer of technologies and training methods for minimally invasive endoscopic spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Percusys® percutaneous pedicle screw-rod system.

The patented Percusys system is a multi-functional implant for use during spinal stabilization procedures. Its unique screw and instrument design enables a safer and more effective surgical technique with minimal steps for the surgeon. The single, small instrument set allows flexibility to perform surgery through a percutaneous, minimally invasive or open approach.

“During development, the main focus was on the ease-of-use of the system,” says Dr. Frank Hassel, specialist for spine surgery from Freiburg, Germany, who was instrumental to the Percusys development. “The idea was to reduce the complexity in instrumentation and simplify stabilization procedures to minimize the potential damage of soft tissues and improve overall patient outcomes.”

Percusys implants comprise single packaged, sterile, and pre-assembled pedicle screws with lengthening shaft and set-screw. All screws are color coded according to their diameter, cannulated, fenestrated, self-cutting and self-drilling. Each surgical step is carried out using the lengthening shaft, which is tightly connected to the tulip. The assembly allows for direct manipulation and does not require additional instrumentation. Shearing off the lengthening shaft can be done by a 360-degree rotation of the shaft breaker.

Percusyscan be usedin combination with the joimax® EndoLIF® O-Cage. “This offers an optimal solution for minimally invasive, endoscopic-assisted access to the intervertebral disc,” says Wolfgang Ries, CEO and founder of joimax. “Percusys® represents the next logical step in the development of endoscopic surgery and further strengthens the joimax position as an expert in this special market segment.”

Endoscopy in Pain Therapy – One day meeting with live surgery – Rome, Nov 24, 2018

Posted on by Antonio Berlen

Endoscopy in Pain Therapy

Focus on Facet Joint – Sacroiliac Joint – Peripheral nerves
New Endoscopic Approach

The aim of the Course of Endoscopy in Pain Therapy is to develop endoscopic techniques in the treatment of common diseases like Low Back Pain, Sacroileitis and Peripheral nerves pain. This course gives the participants an overview of endoscopic possibilities and new approaches in Pain Therapy.

The course is divided in two sessions, a frontal didactical part with an explanation of anatomy and physiopathology of facet joint pain, sacroliliac pain and peripheral nerves disturbs, and it is followed by a practice part with 2 / 3 surgical procedures performed by Dr. Meloncelli and his equipe with a direct explanation of surgical aspects.

At a glance:

One day meeting with live surgery
Rome, November 24, 2018, 9:30 – 17:00

Course director: Dr. Stefano Meloncelli
Secretary: Dr. Ignazio Urti
Faculty: Dr. Marco Divizia, Dr. Giorgio Germani

Download PDF

Location:
Casa di Cura „Valle Giulia“
Via Guiseppe de Notaris 2, Roma
www.clinicavallegiulia.it

Number of Participants: 10
Subscription: 600 Euro

Reservation and information:
Medical Training
phone number:+39 329 771 41 69
email: infomedicaltraining@gmail.com

sponsored by

Diemme ; Dr Meloncelli
SMS Device ; Dr Meloncelli

joimax® Expands Distribution in Italy – Announces New Partnership with Uber Ros S.p.A

Posted on by Antonio Berlen

KARLSRUHE, Germany – (BUSINESS WIRE) – German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, and distributor Uber Ros S.p.A are excited to announce their new partnership for the Italian market, effective immediately.

Under this strategic alliance, Uber Ros will be a full sales and service provider of joimax® products to surgeons and medical practitioners throughout Italy. The partnership allows both companies to expand the renowned joimax® brand via first-rate networks and distribution channels to the Italian health community, ensuring that patients have access to the latest spinal endoscopic technologies.

“We’re looking forward to working with Uber Ros, a strong and well-established partner in Italy,” says joimax® Founder and CEO Wolfgang Ries.<
“Together, we will continue to provide best-in-class service and grow our presence in the Italian spine community while creating a solid business growth strategy,” states Uber Ros President and COO Giorgio Rosati.

In addition, the acclaimed joimax® training and education program for spine physicians, managed under ESPINEA®, the Endoscopic Spine Academy powered by joimax®, will be introduced in Italy. “Uber Ros and joimax® will align all education activities and set-up special workshop programs that offer certified courses to Italian physicians,” says ESPINEA® Chairman Wolfgang Ries.

About Uber Ros S.p.A

Uber Ros S.p.A was founded in Rome in 1986 by Dr. Umberto Rosati and his son Giorgio. It is a Medical Devices Distribution Company active in all Italian territories. Uber Ros promotes and sells high-tech medical devices, mainly specialized in Orthopedics, Trauma Surgery, Neurosurgery, Spine, Maxillo-Facial, Head and Neck surgery (ENT-OTO), Wound Care and Vascular surgery. Uber Ros has a sales organization spread throughout Italy, providing customer service 24 hours on any day of the year. The Company collaborates with the world leading Research Centers, and is involved in the most advanced studies on bioengineering, promoting and supporting scientific research in high-tech emerging fields.

The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® To Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery

Posted on by Antonio Berlen

San Diego, Oct. 20, 2011 – The Society for Minimally Invasive Spine Surgery (SMISS), San Diego, CA and joimax®, Karlsruhe, Germany announced today the signing of an agreement to support the SMISS Registry as a founding sponsor for creation and launch of the SMISS Spine Registry for Minimally Invasive Endoscopic Spine Surgery. The SMISS Spine Registry was designed to collect valuable data concerning decreased hospitalization, recovery times, and complication rates of endoscopic spine procedures, as well as increased quality of life measures, subject satisfaction, and cost effectiveness. In today’s rapidly changing healthcare climate, it is imperative to ensure the ongoing availability of this data regarding efficiencies of care and quality of outcomes.

SMISS has assembled an outstanding research team with extensive experience within the spine field. The Principal Investigator for the Registry, Choll Kim, M. D., Ph.D, Executive Director and Board of Directors Member of SMISS states, “We are excited to partner with joimax® in the launch of the SMISS Registry, a project that will produce the relevant data collection and management necessary for the continued growth of minimally invasive endoscopic spine surgery. The Society will lead the way in the collection of minimally invasive spine surgery outcomes and cost data. SMISS is positioned to become the model for successful spine research.”

“joimax® and SMISS are ideal partners to begin this important project in spinal endoscopy. The data collected will assist both parties in furthering the development of minimally invasive endoscopic spinal surgery, which is a great benefit to patients around the world,” said Wolfgang Ries, CEO and Founder of joimax. “We are pleased to provide funding for this important project.”

This three year, multi-centered project will commence patient enrollment in late 2011. The Registry is expected to enroll a minimum of 250 patients during the first phase of the project.

joimax® hosts SpineWeek symposium, leads live surgery broadcast during CAOS-NASS

Posted on by Antonio Berlen

Karlsruhe, Germany and Singapore, Chengdu/Shanghai, China (May 25, 2016) – joimax®, the global developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, recently hosted an educational symposium and exhibited at SpineWeek in Singapore. SpineWeek takes place every four years and is viewed as one of the most important congresses, representing numerous international society leaders.

“The decision to participate in this congress was the right step to demonstrate our presence in the Asian region,” says Wolfgang Ries, CEO and founder of joimax®. “This year, there was a clear focus on endoscopic treatments by the participating societies, which created a strong interest in our lunch symposium. Approximately 200 attendees gathered to learn about the techniques of endoscopic minimally invasive spine surgery and the benefits of these techniques to both the surgeon and their patients,” continued Ries.

To further validate the company’s expansion and presence in China, joimax® participated in the 9th Congress of the Chinese Association of Orthopaedic Surgeons – North American Spine Society (CAOS/NASS) meeting in Chengdu, China. The company was also involved with the Master Techniques in Spine Surgery Workshop, held on May 20, 2016 in Shanghai, China. Dr. Ralf Wagner, of the Ligamenta Spine Center in Frankfurt, Germany, led the technique-focused workshop and surgery, which was broadcast live to the meeting in Chengdu, as well as online to 30,000 Chinese surgeons.

joimax® Organizes its First Online Endoscopic Spine Symposium

Posted on by Antonio Berlen

Karlsruhe (GER) — joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, held its first online global symposium, “Endoscopic Spine Surgery – Indications, Technology and Limitations”, at its headquarters in the Training and Education Center (TEC) in Karlsruhe-Germany, on April 24-25, 2020.

In view of the coronavirus restrictions introduced by many governments, in March,  joimax® began holding weekly webinars, in partnership with key surgeons, to demonstrate the latest endoscopic techniques. The training sessions culminated with a two-day Symposium, full of live discussions and video demonstrations, scheduled during Western and Eastern time zones.

joimax first online endoscopic spine symposium, April 2020

On April 24, joimax® Founder and CEO Wolfgang Ries, moderated a panel with faculty members Ralf Wagner, MD (Ligamenta Spine Center Frankfurt-Germany) and Christoph Hofstetter, MD, PhD (University of Washington Medicine, Neurosurgery Department, Seattle/USA). The following day, faculty member, Junseok Bae, MD (President of Wooridul Spine Hospital Seoul, South Korea), joined the panel.

On both days, the agenda included a theoretical part focused on transforaminal and interlaminar indications, and the general possibilities of endoscopy from lumbar to thoracic to cervical, as well as a hands-on lab portion. In the wet lab, Dr. Ralf Wagner demonstrated the joimax® product application of TESSYS® and iLESSYS® in specific indications. Moreover, there were presentations of Intracs® em , the first electromagnetic system for endoscopic spine applications that can navigate instruments directly at the tip. This navigation system combines lateral and AP images of the C-arm with CT scan, providing surgeons with most accurate views of the target region.

The Symposium also featured special guests: Dr. Menno Iprenburg (Iprenburg Spine Clinic, Veenhuizen, Netherlands) and Prof. Alastair Gibson (The Royal Infirmary of Edinburgh, Edinburgh Scotland); both board members of ESPINEA® Academy, who gave their valued input, based on their long-lasting experience.

“This is the  future of digital education and a great way to virtually meet and learn,” stated Dr. Iprenburg.  Prof. Gibson added, “excellent Symposium; it couldn’t get any better”.

The Symposium marked a major milestone, with 430 participants. Surgeons from all over the world joined this unique online education program and stimulating Q&A session.

When safe, joimax® will transition back to on-site workshops and trainings, but in the  meantimewill continue with its attention-grabbing online webinars.

joimax® at the autumn congresses: EuroSpine Liverpool and NASS New Orleans

Posted on by Antonio Berlen

Karlsruhe/Irvine, October 29th 2013

Dear partners and friends,

it was our great pleasure to launch and present our latest product developments at the major spine congresses: EuroSpine as the most important spine congress on the European level and NASS as the most renowned and biggest one in the US. Please find here some impressions of both of the venues in Liverpool and New Orleans.

At both congresses our novel EndoLIF® and Percusys® (both not yet FDA cleared) technologies for endoscopic lumbar interbody fusion and percutaneous fixation were in the limelight, besides the earlier in the year launched CESSYS® and Multiuse RT systems.

We are now looking forward to welcoming you at our booth at the Annual Meeting of SMISS November 1 to 3, 2013 and DWG, the German Spine Society, December 5 to 7, 2013. See you in Las Vegas and Frankfurt!

EUROSPINE 2013, Liverpool

NASS 2013, New Orleans

joimax® celebrates its 10th anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

Posted on by Antonio Berlen

Karlsruhe, Germany – April 11th, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax® organized the presentation of its latest systems like the TESSYS® ISeeU and iLESSYS® Delta in product trainings as well as newest tools for endoscopic treatment in an exhibition hall. The program was supported by joimax® Faculty Members from Europe, USA and other countries. In the course of the meeting a Chinese Faculty Team with 13 members was inaugurated by Wolfgang Ries, Founder and CEO of joimax® and Qin-Guang You, President of joimax® China. ”Due to the growing education and training needs in the Asian region the time has come to form a local team for this important market”, explains Wolfgang Ries. “It is a great honor to lead this team and to support the further growth of joimax®”, says the head of the Faculty Team, Prof. Yue Zhou from the Third Military Medical University in Chongqing. He was awarded with the joimax® Handshake Award in Gold for his exceptional commitment and the members of the group received the joimax® Handshake Award in Silver.

10 years Joimax and China.

After very satisfying growing sales figures in 2016 (31 % growth vs. 2015), joimax® is proud to announce a jump in sales in the first quarter 2017. Consolidated figures show an increase of 60 % compared to the same period of last year. “This is a very encouraging development, showing the continuing expansion and growth of the group”, states Wolfgang Ries, Founder and CEO of joimax®.

joimax® Recieves FDA Clearance to Market EndoLIF® Delta-Cage and DoubleWedge-Cage in the USA

Posted on by Antonio Berlen

Karlsruhe (GER) — German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce that it has received FDA clearance to market the EndoLIF® Delta-Cage and EndoLIF® DoubleWedge-Cage in the United States. Delta-Cages and DoubleWedge-Cages are intended for intervertebral body fusion procedures for various diseases of the lumbar spine, such as degenerative disc disease.

joimax cage family EndoLIF

Now in its 20th anniversary year, joimax® sets another milestone by providing a family of 3D printed titanium cages. The complete EndoLIF® product portfolio consists of the Delta-Cage, the DoubleWedge-Cage, and the O/On-Cage. All three models are designed with special features:

  • 3D printed titanium for excellent bone ingrowth, fillable with bone or bone substitute material, pre- or post-insertiony
  • Anatomical shape and lordotic correction options for OLIF, TLIF, and PLIF procedures
  • “Over-the-wire” implantation for optimal targeted positioning in the intervertebral disc space
  • Endoscopic control of all surgical steps due to the EndoLIF® platform technology

“It is impressive how well these cages ensure primary stability, especially the DoubleWedge-Cage,” says Dr. Ralf Wagner, head surgeon and founder of the Ligamenta Spine Centre in Frankfurt.

Many other experts including, Dr. Florian Zentz, head surgeon of the spine center in Tutzing (Munich), Dr. Ricardo Casal Grau, orthospine surgeon from Madrid, and Dr. J. N. Alastair Gibson, spinal surgeon from Edinburgh, supported the development of the joimax® cages.

“With FDA clearance of two of our cages, our EndoLIF® platform gets more complete; the next major step in endoscopic spinal surgery is endoscopically-assisted fusion,” says joimax® Founder and CEO Wolfgang Ries. “More and more centers are proving the efficacy of these procedures in studies, demonstrating once again the major benefits of endoscopy in fusion. So far, our cages are well established in Europe and in selected centers in Asia, and now we are entering the USA, the biggest market for spinal fusion”.